The Borna Disease Virus Tragedy
December 5, 2006The Robert Koch Institute in Berlin (remember Koch’s Postulates?) earlier this year cancelled its research into Borna Disease Virus (BDV). That is really regrettable, because BDV, a neurotropic virus, may cause depression and bipolar disorder. BDV may be transmitted by blood transfusions; research on this is being carried out in Australia. There may even be an effective cure; an antiviral drug, amantadine sulfate, approved for use against the common flu.
Given the prevalence of depression and bipolar disorder, you should have thought that a decent randomized trial would have been carried out. A small trial would not cost more that a couple of hundred thousand dollars. But amantadine is a 30 year old drug, no longer covered by patents. There is practically no incentive for pharmaceutical firms to finance such a study. So far there has been none. Given the potential huge benefits and the low cost, that is a tragedy.
In the meantime, German and Austrian doctors are using amantadine and reportedly getting good results. However, we still need the solid evidence we would get from a well-designed randomized controlled trial.
For background, read this article in Discovery, a more recent paper here. See also Read the rest of this entry »
Posted by Lars Smith
